Publications

/* Container and basics */ img { max-width: 100%; height: auto; } /* Offer header styling */ .offer-header { background-color: #42893e; color: white; padding: 10px 20px; border-radius: 8px; text-align: center; font-weight: bold; font-size: 16px; margin-bottom: 20px; } /* Intro section styling */ .intro-section { background-color: #fff; padding: 20px; margin-bottom: 30px; box-shadow: 0 2px 5px rgba(0,0,0,0...)

Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis

Kristin Blom, Peter Nygren, Rolf Larsson, Claes R Andersson

Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC

P Roy, C Canet-Jourdan, M Annereau, O Zajac, M Gelli, S Broutin, L Mercier, A Paci, F Lemare, M Ducreux, D Elias, D Malka, V Boige, D Goéré, F Jaulin

Development and Applicability of Integrative Tumor Response Assays for Metastatic Colorectal Cancer

Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer

Woong Bae Ji, Jun Won Um, Je Seock Ryu, Kwang Dae Hong, Jung Sik Kim, Byung Wook Min, Sung Yeop Joung, Ju Han Lee, Young Sik Kim

Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancer

Christophe Bounaix Morand du Puch, Michelle Nouaille, Stéphanie Giraud, Anaïs Labrunie, Sandrine Luce, Pierre-Marie Preux, François Labrousse, Alain Gainant 8, Nicole Tubiana-Mathieu, Valérie Le Brun-Ly , Denis Valleix, Angélique Guillaudeau, Laura Mesturoux, Béma Coulibaly, Christophe Lautrette, Muriel Mathonnet

Sedimentation field flow fractionation monitoring of in vitro enrichment in cancer stem cells by specific serum-free culture medium

Mélin C, Perraud A, Bounaix Morand du Puch C, Loum E, Giraud S, Cardot P, Jauberteau MO, Lautrette C, Battu S, Mathonnet M. 

Discrimination of colorectal cancer cell lines using microwave biosensors

Zhang LY, Bounaix Morand du Puch C, Dalmay C, Lacroix A, Landoulsi A, Leroy J, Mélin C, Lalloué F, Battu S, Lautrette C, Giraud S, Bessaudou A, Blondy P, Jauberteau MO, Pothier A.

Oncogramme, an Adapted Method for Individualized Tumour Response Testing of Ovary Cancer Treatments

Giraud S, Croce S, Bessette B, Stoeckle E, Guyon F, Mac Grogan G, Floquet A, Velasco V, Mannina C, Lautrette C. 

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy

Kristin Blom, Peter Nygren, Jonathan Alvarsson, Rolf Larsson, Claes R Andersson

In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer

Hye Youn Kwon, Im-Kyung Kim, Jeonghyun Kang, Seung-Kook Sohn, Kang Young Lee

Precision medicine for cancer with next-generation functional diagnostics

Adam A. Friedman, Anthony Letai, David E. Fisher and Keith T. Flaherty

Role of Conventional Chemosensitivity Test and Tissue Biomarker Expression in Predicting Response to Treatment of Peritoneal Carcinomatosis From Colon Cancer

ChiaraArienti, AnnaTesei, Giorgio Maria Verdecchia, Massimo Framarini, Salvatore Virzì, Antonio Grassi, Emanuela Scarpi, Livia Turci, Rosella Silvestrini, Dino Amadori, Wainer Zoli

Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer

Katsushi Takebayashi, Eiji Mekata, Hiromichi Sonoda, Tomoharu Shimizu, Yoshihiro Endo, Tohru Tani

Applicability of Histoculture Drug Response Assays in Colorectal Cancer Chemotherapy

Oncogramme responses of breast tumour cells treated with herceptin correlate with HER2/C-ERB B2 pathological status

Oncogramme, a new promising method for individualized breast tumour response testing for cancer treatment

Giraud S, Loum E, Bessette B, Fermeaux V, Lautrette C. 

Oncogramme, a new individualized tumor response testing method: application to colon cancer

Loum E, Giraud S, Bessette B, Battu S, Mathonnet M, Lautrette C.